Over but not gone: lingering epigenetic effects of COVID-19

Trends Immunol. 2023 Sep 11:S1471-4906(23)00180-1. doi: 10.1016/j.it.2023.08.012. Online ahead of print.ABSTRACT'Long COVID' affects nearly one in five adults who have had coronavirus disease 2019 (COVID-19), yet the mechanisms underlying this disorder remain poorly understood. In a new study, Cheong et al. show that the epigenetic and transcriptional state of myeloid immune cells and their progenitors are durably altered in patients following severe COVID-19.PMID:37704548 | DOI:10.1016/j.it.2023.08.012
Source: Trends in Immunology - Category: Allergy & Immunology Authors: Source Type: research